Table 1 Post-mortem tissue donor demographics
Group | Case code | Age (y) | Sex | PMD (h) | fALS/sALS | |
|---|---|---|---|---|---|---|
Neurologically normal controls (n = 10) | H211 | 41 | M | 8 | – | |
H215 | 67 | F | 23.5 | – | ||
H226 | 73 | F | 48 | – | ||
H230 | 57 | F | 32 | – | ||
H238 | 63 | F | 16 | – | ||
H240 | 73 | M | 26.5 | – | ||
H242 | 61 | M | 19.5 | – | ||
H245 | 63 | M | 20 | – | ||
H247 | 51 | M | 31 | – | ||
H249 | 77 | F | 17 | – | ||
Control mean ± SD | – | 62.60 ± 10.95 | 5 M:5F | 24.15 ± 11.06 | – | |
ALS (n = 10) | Stage 1–3 (n = 5) | MN11 | 77 | F | 18 | fALS (unknown) |
MN14 | 59 | F | 19 | fALS (unknown) | ||
MN16 | 69 | M | 16.5 | sALS | ||
MN20 | 85 | M | 15 | sALS | ||
MN25 | 71 | M | 23.5 | sALS | ||
Stage 4 (n = 5) | MN13 | 55 | M | 10 | sALS | |
MN15 | 54 | F | 18 | sALS | ||
MN19 | 75 | M | 20.5 | sALS | ||
MN29 | 72 | M | 24 | sALS | ||
MN30 | 84 | F | 17.5 | sALS | ||
ALS mean ± SD | – | 70.10 ± 11.07 | 6 M:4F | 18.20 ± 4.063 | – | |